ICM
SGC icon

Invenomic Capital Management’s Superior Group of Companies SGC Stock Holding History

Invenomic Capital Management’s Portfolio SGC Stock Details SGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-179,855
Closed -$1.81M – 176
2022
Q4 		$1.81M Buy
179,855
+9,070
+5% +$87.5K 0.12% 123
2022
Q3 		$1.52M Buy
+170,785
New +$2.46M 0.13% 130

Other funds holding SGC

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invenomic Capital Management's SGC Position: Q1 2023 in Review

Invenomic Capital Management sold out of Superior Group of Companies (SGC) in Q1 2023, closing a stake of 179,855 shares — an estimated $1.81M sold.

Invenomic Capital Management first reported a position in SGC in Q3 2022 and held it in 2 quarters. The position peaked at $1.81M in Q4 2022. 55 funds tracked by Wall St. Rank hold SGC as of Q1 2023.

  • Invenomic Capital Management reported no remaining Superior Group of Companies position as of Q1 2023 after selling out during the quarter.
  • Invenomic Capital Management sold 179,855 Superior Group of Companies shares in Q1 2023, an estimated $1.81M.
  • Invenomic Capital Management first reported a position in Superior Group of Companies in Q3 2022 and held it in 2 quarters.
  • Invenomic Capital Management's Superior Group of Companies position peaked at $1.81M in Q4 2022.
  • 55 funds tracked by Wall St. Rank held Superior Group of Companies as of Q1 2023.

Based on Invenomic Capital Management's 13F filing for Q1 2023, filed 15 May 2023.